Patent · US Expired

1-glyoxylamide indolizines for treating cancer

US6861436B2 · kind B2 · utility

2Cited by
1References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2002
Grant dateMar 1, 2005
Priority date—
Expiry dateJan 27, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed is a compound represented by Structural Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.